| Year |
Citation |
Score |
| 2020 |
Hu X, Wu Q, Zhang J, Kim J, Chen X, Hartman AA, Eastman AE, Park IH, Guo S. Reprogramming progressive cells display low CAG promoter activity. Stem Cells (Dayton, Ohio). PMID 33075202 DOI: 10.1002/stem.3295 |
0.323 |
|
| 2020 |
Wang K, Zhang H, He Y, Jiang Q, Tanaka Y, Park IH, Pober JS, Min W, Zhou HJ. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA120314586. PMID 32640906 DOI: 10.1161/Atvbaha.120.314586 |
0.341 |
|
| 2020 |
Xiang Y, Tanaka Y, Patterson B, Hwang SM, Hysolli E, Cakir B, Kim KY, Wang W, Kang YJ, Clement EM, Zhong M, Lee SH, Cho YS, Patra P, Sullivan GJ, ... ... Park IH, et al. Dysregulation of BRD4 Function Underlies the Functional Abnormalities of MeCP2 Mutant Neurons. Molecular Cell. PMID 32526163 DOI: 10.1016/J.Molcel.2020.05.016 |
0.347 |
|
| 2020 |
Yoon Y, Kim HS, Jeon I, Noh JE, Park HJ, Lee S, Park IH, Stevanato L, Hicks C, Corteling R, Barker RA, Sinden JD, Song J. Implantation of the clinical-grade human neural stem cell line, CTX0E03, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease. Stem Cells (Dayton, Ohio). PMID 32374064 DOI: 10.1002/Stem.3191 |
0.337 |
|
| 2019 |
Cakir B, Xiang Y, Tanaka Y, Kural MH, Parent M, Kang YJ, Chapeton K, Patterson B, Yuan Y, He CS, Raredon MSB, Dengelegi J, Kim KY, Sun P, Zhong M, ... ... Park IH, et al. Engineering of human brain organoids with a functional vascular-like system. Nature Methods. PMID 31591580 DOI: 10.1038/S41592-019-0586-5 |
0.33 |
|
| 2019 |
Belair C, Sim S, Kim KY, Tanaka Y, Park IH, Wolin SL. The RNA exosome nuclease complex regulates human embryonic stem cell differentiation. The Journal of Cell Biology. PMID 31308215 DOI: 10.1083/Jcb.201811148 |
0.399 |
|
| 2019 |
Xiang Y, Tanaka Y, Cakir B, Patterson B, Kim KY, Sun P, Kang YJ, Zhong M, Liu X, Patra P, Lee SH, Weissman SM, Park IH. hESC-Derived Thalamic Organoids Form Reciprocal Projections When Fused with Cortical Organoids. Cell Stem Cell. PMID 30799279 DOI: 10.1016/J.Stem.2018.12.015 |
0.341 |
|
| 2018 |
Patterson B, Tanaka Y, Park IH. Correction to: New Advances in Human X Chromosome Status from a Developmental and Stem Cell Biology. Tissue Engineering and Regenerative Medicine. 15: 125. PMID 30603540 DOI: 10.1007/S13770-017-0111-9 |
0.349 |
|
| 2017 |
Patterson B, Tanaka Y, Park IH. New Advances in Human X chromosome status from a Developmental and Stem Cell Biology. Tissue Engineering and Regenerative Medicine. 14: 643-652. PMID 29276809 DOI: 10.1007/S13770-017-0096-4 |
0.393 |
|
| 2017 |
Xiang Y, Tanaka Y, Patterson B, Kang YJ, Govindaiah G, Roselaar N, Cakir B, Kim KY, Lombroso AP, Hwang SM, Zhong M, Stanley EG, Elefanty AG, Naegele JR, Lee SH, ... ... Park IH, et al. Fusion of Regionally Specified hPSC-Derived Organoids Models Human Brain Development and Interneuron Migration. Cell Stem Cell. PMID 28757360 DOI: 10.1016/J.Stem.2017.07.007 |
0.346 |
|
| 2017 |
Han L, Wu HJ, Zhu H, Kim KY, Marjani SL, Riester M, Euskirchen G, Zi X, Yang J, Han J, Snyder M, Park IH, Irizarry R, Weissman SM, Michor F, et al. Bisulfite-independent analysis of CpG island methylation enables genome-scale stratification of single cells. Nucleic Acids Research. PMID 28126923 DOI: 10.1093/Nar/Gkx026 |
0.35 |
|
| 2016 |
Yang J, Tanaka Y, Seay M, Li Z, Jin J, Garmire LX, Zhu X, Taylor A, Li W, Euskirchen G, Halene S, Kluger Y, Snyder MP, Park IH, Pan X, et al. Single cell transcriptomics reveals unanticipated features of early hematopoietic precursors. Nucleic Acids Research. PMID 28003475 DOI: 10.1093/Nar/Gkw1214 |
0.425 |
|
| 2016 |
Liu R, Kim KY, Jung YW, Park IH. Dnmt1 regulates the myogenic lineage specification of muscle stem cells. Scientific Reports. 6: 35355. PMID 27752090 DOI: 10.1038/Srep35355 |
0.368 |
|
| 2016 |
Park CY, Sung JJ, Choi SH, Lee DR, Park IH, Kim DW. Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9. Nature Protocols. 11: 2154-2169. PMID 27711053 DOI: 10.1038/Nprot.2016.129 |
0.305 |
|
| 2015 |
Xiang Y, Kim KY, Gelernter J, Park IH, Zhang H. Ethanol Upregulates NMDA Receptor Subunit Gene Expression in Human Embryonic Stem Cell-Derived Cortical Neurons. Plos One. 10: e0134907. PMID 26266540 DOI: 10.1371/Journal.Pone.0134907 |
0.308 |
|
| 2015 |
Tanaka Y, Hysolli E, Su J, Xiang Y, Kim KY, Zhong M, Li Y, Heydari K, Euskirchen G, Snyder MP, Pan X, Weissman SM, Park IH. Transcriptome Signature and Regulation in Human Somatic Cell Reprogramming. Stem Cell Reports. 4: 1125-39. PMID 26004630 DOI: 10.1016/J.Stemcr.2015.04.009 |
0.442 |
|
| 2015 |
Kwon YW, Paek JS, Cho HJ, Lee CS, Lee HJ, Park IH, Roh TY, Kang CM, Yang HM, Park YB, Kim HS. Role of Zscan4 in secondary murine iPSC derivation mediated by protein extracts of ESC or iPSC. Biomaterials. 59: 102-15. PMID 25956855 DOI: 10.1016/j.biomaterials.2015.03.031 |
0.317 |
|
| 2015 |
Astle J, Xiang Y, Rongvaux A, Weibel C, Elizabeth H, Halene S, Park I, Flavell R. Developing a Model of Human Pluripotent to Hematopoietic Stem Cell Development in Mistrg Mice Blood. 126: 4755-4755. DOI: 10.1182/Blood.V126.23.4755.4755 |
0.401 |
|
| 2014 |
Kim KY, Hysolli E, Tanaka Y, Wang B, Jung YW, Pan X, Weissman SM, Park IH. X Chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming. Stem Cell Reports. 2: 896-909. PMID 24936474 DOI: 10.1016/J.Stemcr.2014.04.003 |
0.319 |
|
| 2014 |
Jeon I, Choi C, Lee N, Im W, Kim M, Oh SH, Park IH, Kim HS, Song J. In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease. International Journal of Stem Cells. 7: 43-7. PMID 24921027 DOI: 10.15283/Ijsc.2014.7.1.43 |
0.351 |
|
| 2014 |
Tanaka Y, Kim KY, Zhong M, Pan X, Weissman SM, Park IH. Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2). Human Molecular Genetics. 23: 1045-55. PMID 24129406 DOI: 10.1093/Hmg/Ddt500 |
0.429 |
|
| 2013 |
Hysolli E, Park IH. Trivalent chromatin marks the way in. Cell Stem Cell. 13: 510-2. PMID 24209756 DOI: 10.1016/J.Stem.2013.10.007 |
0.347 |
|
| 2013 |
Larimore J, Ryder PV, Kim KY, Ambrose LA, Chapleau C, Calfa G, Gross C, Bassell GJ, Pozzo-Miller L, Smith Y, Talbot K, Park IH, Faundez V. MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons. Plos One. 8: e65069. PMID 23750231 DOI: 10.1371/Journal.Pone.0065069 |
0.338 |
|
| 2013 |
Dajani R, Koo SE, Sullivan GJ, Park IH. Investigation of Rett syndrome using pluripotent stem cells. Journal of Cellular Biochemistry. 114: 2446-53. PMID 23744605 DOI: 10.1002/Jcb.24597 |
0.413 |
|
| 2013 |
Lee JB, Werbowetski-Ogilvie TE, Lee JH, McIntyre BA, Schnerch A, Hong SH, Park IH, Daley GQ, Bernstein ID, Bhatia M. Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells. Blood. 122: 1162-73. PMID 23733337 DOI: 10.1182/Blood-2012-12-471649 |
0.363 |
|
| 2013 |
Tulpule A, Kelley JM, Lensch MW, McPherson J, Park IH, Hartung O, Nakamura T, Schlaeger TM, Shimamura A, Daley GQ. Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction. Cell Stem Cell. 12: 727-36. PMID 23602541 DOI: 10.1016/J.Stem.2013.04.002 |
0.315 |
|
| 2013 |
Lee ST, Gong SP, Yum KE, Lee EJ, Lee CH, Choi JH, Kim DY, Han H, Kim KS, Hysolli E, Ahn JY, Park IH, Han JY, Jeong JW, Lim JM. Transformation of somatic cells into stem cell-like cells under a stromal niche. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2644-56. PMID 23580613 DOI: 10.1096/fj.12-223065 |
0.336 |
|
| 2013 |
Siller R, Greenhough S, Park IH, Sullivan GJ. Modelling human disease with pluripotent stem cells. Current Gene Therapy. 13: 99-110. PMID 23444871 DOI: 10.2174/1566523211313020004 |
0.366 |
|
| 2013 |
Pan X, Durrett RE, Zhu H, Tanaka Y, Li Y, Zi X, Marjani SL, Euskirchen G, Ma C, Lamotte RH, Park IH, Snyder MP, Mason CE, Weissman SM. Two methods for full-length RNA sequencing for low quantities of cells and single cells. Proceedings of the National Academy of Sciences of the United States of America. 110: 594-9. PMID 23267071 DOI: 10.1073/Pnas.1217322109 |
0.339 |
|
| 2013 |
Chang DJ, Lee N, Park IH, Choi C, Jeon I, Kwon J, Oh SH, Shin DA, Do JT, Lee DR, Lee H, Moon H, Hong KS, Daley GQ, Song J. Therapeutic potential of human induced pluripotent stem cells in experimental stroke. Cell Transplantation. 22: 1427-40. PMID 23044029 DOI: 10.3727/096368912X657314 |
0.32 |
|
| 2012 |
Tanaka Y, Chung L, Park IH. Impact of retrotransposons in pluripotent stem cells. Molecules and Cells. 34: 509-16. PMID 23135636 DOI: 10.1007/S10059-012-0242-8 |
0.376 |
|
| 2012 |
Maclean GA, Menne TF, Guo G, Sanchez DJ, Park IH, Daley GQ, Orkin SH. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 17567-72. PMID 23045682 DOI: 10.1182/Blood.V118.21.921.921 |
0.406 |
|
| 2012 |
Ge X, Ren Y, Bartulos O, Lee MY, Yue Z, Kim KY, Li W, Amos PJ, Bozkulak EC, Iyer A, Zheng W, Zhao H, Martin KA, Kotton DN, Tellides G, ... Park IH, et al. Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation. 126: 1695-704. PMID 22914687 DOI: 10.1161/Circulationaha.112.116996 |
0.439 |
|
| 2012 |
Kim KY, Jung YW, Sullivan GJ, Chung L, Park IH. Cellular reprogramming: a novel tool for investigating autism spectrum disorders. Trends in Molecular Medicine. 18: 463-71. PMID 22771169 DOI: 10.1016/J.Molmed.2012.06.002 |
0.328 |
|
| 2012 |
Chae JI, Kim DW, Lee N, Jeon YJ, Jeon I, Kwon J, Kim J, Soh Y, Lee DS, Seo KS, Choi NJ, Park BC, Kang SH, Ryu J, Oh SH, ... ... Park IH, et al. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. The Biochemical Journal. 446: 359-71. PMID 22694310 DOI: 10.1042/Bj20111495 |
0.316 |
|
| 2012 |
Loh YH, Yang JC, De Los Angeles A, Guo C, Cherry A, Rossi DJ, Park IH, Daley GQ. Excision of a viral reprogramming cassette by delivery of synthetic Cre mRNA. Current Protocols in Stem Cell Biology. Unit4A.5. PMID 22605648 DOI: 10.1002/9780470151808.Sc04A05S21 |
0.412 |
|
| 2012 |
Kim KY, Hysolli E, Park IH. Reprogramming human somatic cells into induced pluripotent stem cells (iPSCs) using retroviral vector with GFP. Journal of Visualized Experiments : Jove. PMID 22491226 DOI: 10.3791/3804 |
0.429 |
|
| 2012 |
Müller LU, Milsom MD, Harris CE, Vyas R, Brumme KM, Parmar K, Moreau LA, Schambach A, Park IH, London WB, Strait K, Schlaeger T, Devine AL, Grassman E, D'Andrea A, et al. Overcoming reprogramming resistance of Fanconi anemia cells. Blood. 119: 5449-57. PMID 22371882 DOI: 10.1182/Blood-2012-02-408674 |
0.463 |
|
| 2012 |
Zhou XL, Sullivan GJ, Sun P, Park IH. Humanized murine model for HBV and HCV using human induced pluripotent stem cells. Archives of Pharmacal Research. 35: 261-9. PMID 22370780 DOI: 10.1007/S12272-012-0206-8 |
0.333 |
|
| 2012 |
Jung YW, Hysolli E, Kim KY, Tanaka Y, Park IH. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. Current Opinion in Neurology. 25: 125-30. PMID 22357218 DOI: 10.1097/Wco.0B013E3283518226 |
0.363 |
|
| 2012 |
Hysolli E, Jung YW, Tanaka Y, Kim KY, Park IH. The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome. Cell Cycle (Georgetown, Tex.). 11: 229-35. PMID 22234239 DOI: 10.4161/Cc.11.2.18998 |
0.353 |
|
| 2012 |
Konantz M, Grauer M, Grzywna S, Park I, Daley GQ, Kanz L, Lengerke C. A Dual Role of Evi-1 During Developmental Hematopoiesis Blood. 120: 765-765. DOI: 10.1182/Blood.V120.21.765.765 |
0.45 |
|
| 2011 |
Ballabeni A, Park IH, Zhao R, Wang W, Lerou PH, Daley GQ, Kirschner MW. Cell cycle adaptations of embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 19252-7. PMID 22084091 DOI: 10.1073/Pnas.1116794108 |
0.396 |
|
| 2011 |
Kim KY, Hysolli E, Park IH. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proceedings of the National Academy of Sciences of the United States of America. 108: 14169-74. PMID 21807996 DOI: 10.1073/Pnas.1018979108 |
0.386 |
|
| 2011 |
Jang J, Kang HC, Kim HS, Kim JY, Huh YJ, Kim DS, Yoo JE, Lee JA, Lim B, Lee J, Yoon TM, Park IH, Hwang DY, Daley GQ, Kim DW. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Annals of Neurology. 70: 402-9. PMID 21721033 DOI: 10.1002/Ana.22486 |
0.359 |
|
| 2011 |
Tucker BA, Park IH, Qi SD, Klassen HJ, Jiang C, Yao J, Redenti S, Daley GQ, Young MJ. Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. Plos One. 6: e18992. PMID 21559507 DOI: 10.1371/Journal.Pone.0018992 |
0.33 |
|
| 2011 |
Nostro MC, Sarangi F, Ogawa S, Holtzinger A, Corneo B, Li X, Micallef SJ, Park IH, Basford C, Wheeler MB, Daley GQ, Elefanty AG, Stanley EG, Keller G. Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development (Cambridge, England). 138: 861-71. PMID 21270052 DOI: 10.1242/dev.055236 |
0.448 |
|
| 2011 |
Pessach IM, Ordovas-Montanes J, Zhang SY, Casanova JL, Giliani S, Gennery AR, Al-Herz W, Manos PD, Schlaeger TM, Park IH, Rucci F, Agarwal S, Mostoslavsky G, Daley GQ, Notarangelo LD. Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. The Journal of Allergy and Clinical Immunology. 127: 1400-7.e4. PMID 21185069 DOI: 10.1016/J.Jaci.2010.11.008 |
0.441 |
|
| 2011 |
Jin J, Kwon YW, Paek JS, Cho HJ, Yu J, Lee JY, Chu IS, Park IH, Park YB, Kim HS, Kim Y. Analysis of differential proteomes of induced pluripotent stem cells by protein-based reprogramming of fibroblasts. Journal of Proteome Research. 10: 977-89. PMID 21175196 DOI: 10.1021/pr100624f |
0.339 |
|
| 2011 |
Nostro MC, Sarangi F, Ogawa S, Holtzinger A, Corneo B, Li X, Micallef SJ, Park I, Basford C, Wheeler MB, Daley GQ, Elefanty AG, Stanley EG, Keller G. Stage-specific signaling through TGF family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells Journal of Cell Science. 124: e1-e1. DOI: 10.1242/JCS.087957 |
0.301 |
|
| 2011 |
Mueller L, Milsom MD, Harris C, Vyas R, Brumme K, Parmar K, Schambach A, Grassman E, Park I, Wendy L, Strait K, Schlaeger T, Devine AL, D'Andrea AD, Daley GQ, et al. Gene-Correction Rescues Reprogramming of Fanconi Anemia Fibroblasts and Enables Hematopoietic Differentiation of FA Induced Pluripotent Stem Cells in Vitro and In Vivo Blood. 118: 672-672. DOI: 10.1182/Blood.V118.21.672.672 |
0.431 |
|
| 2011 |
Konantz M, Grauer M, Grzywna S, Brugman M, Kanz L, Park I, Daley GQ, Baum C, Lengerke C. Evi-1 Regulates Myelopoiesis and Hematopoietic Stem Cell Development in Zebrafish and Human Pluripotent Stem Cells Blood. 118: 1281-1281. DOI: 10.1182/Blood.V118.21.1281.1281 |
0.468 |
|
| 2010 |
Neveu P, Kye MJ, Qi S, Buchholz DE, Clegg DO, Sahin M, Park IH, Kim KS, Daley GQ, Kornblum HI, Shraiman BI, Kosik KS. MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell. 7: 671-81. PMID 21112562 DOI: 10.1016/J.Stem.2010.11.012 |
0.37 |
|
| 2010 |
Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, Manos PD, Datta S, Lander ES, Schlaeger TM, Daley GQ, et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nature Genetics. 42: 1113-7. PMID 21057500 DOI: 10.1038/Ng.710 |
0.34 |
|
| 2010 |
Kim DS, Lee JS, Leem JW, Huh YJ, Kim JY, Kim HS, Park IH, Daley GQ, Hwang DY, Kim DW. Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Reviews. 6: 270-81. PMID 20376579 DOI: 10.1007/S12015-010-9138-1 |
0.459 |
|
| 2010 |
Agarwal S, Loh YH, McLoughlin EM, Huang J, Park IH, Miller JD, Huo H, Okuka M, Dos Reis RM, Loewer S, Ng HH, Keefe DL, Goldman FD, Klingelhutz AJ, Liu L, et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature. 464: 292-6. PMID 20164838 DOI: 10.1038/Nature08792 |
0.39 |
|
| 2010 |
Park IH. DYS-HAC-iPS cells: The combination of gene and cell therapy to treat duchenne muscular dystrophy Molecular Therapy. 18: 238-240. PMID 20125163 DOI: 10.1038/Mt.2009.303 |
0.343 |
|
| 2010 |
Grigoriadis AE, Kennedy M, Bozec A, Brunton F, Stenbeck G, Park IH, Wagner EF, Keller GM. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood. 115: 2769-76. PMID 20065292 DOI: 10.1182/Blood-2009-07-234690 |
0.41 |
|
| 2010 |
Grauer M, Konantz M, Niebuhr NI, Kanz L, Park I, Daley GQ, Lengerke C. Hematopoietic development from human induced pluripotent stem cells F1000research. 1. DOI: 10.7490/F1000Research.127.1 |
0.409 |
|
| 2009 |
Lee JH, Park IH, Gao Y, Li JB, Li Z, Daley GQ, Zhang K, Church GM. A robust approach to identifying tissue-specific gene expression regulatory variants using personalized human induced pluripotent stem cells. Plos Genetics. 5: e1000718. PMID 19911041 DOI: 10.1371/Journal.Pgen.1000718 |
0.402 |
|
| 2009 |
Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O, Rho J, Ince TA, Daley GQ, Schlaeger TM. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nature Biotechnology. 27: 1033-7. PMID 19826408 DOI: 10.1038/Nbt.1580 |
0.334 |
|
| 2009 |
Lengerke C, Grauer M, Niebuhr NI, Riedt T, Kanz L, Park IH, Daley GQ. Hematopoietic development from human induced pluripotent stem cells. Annals of the New York Academy of Sciences. 1176: 219-27. PMID 19796250 DOI: 10.1111/J.1749-6632.2009.04606.X |
0.449 |
|
| 2009 |
Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation. 120: 1513-23. PMID 19786631 DOI: 10.1161/Circulationaha.109.868885 |
0.414 |
|
| 2009 |
West JA, Viswanathan SR, Yabuuchi A, Cunniff K, Takeuchi A, Park IH, Sero JE, Zhu H, Perez-Atayde A, Frazier AL, Surani MA, Daley GQ. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature. 460: 909-13. PMID 19578360 DOI: 10.1038/Nature08210 |
0.465 |
|
| 2009 |
Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J, Egli D, Maherali N, Park IH, Yu J, Daley GQ, Eggan K, Hochedlinger K, Thomson J, Wang W, et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nature Biotechnology. 27: 353-60. PMID 19330000 DOI: 10.1038/Nbt.1530 |
0.34 |
|
| 2009 |
Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, Park IH, Xie B, Daley GQ, Church GM. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nature Biotechnology. 27: 361-8. PMID 19329998 DOI: 10.1038/Nbt.1533 |
0.318 |
|
| 2009 |
Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ. Generation of induced pluripotent stem cells from human blood. Blood. 113: 5476-9. PMID 19299331 DOI: 10.1182/Blood-2009-02-204800 |
0.442 |
|
| 2009 |
Park IH, Daley GQ. Human iPS cell derivation/reprogramming. Current Protocols in Stem Cell Biology. Unit 4A.1. PMID 19170021 DOI: 10.1002/9780470151808.Sc04A01S8 |
0.444 |
|
| 2009 |
Agarwal S, Loh Y, McLoughlin EM, Huang J, Park I, Miller JD, Huo H, Okuka M, Reis RMd, Loewer S, Keefe D, Goldman FD, Klingelhutz A, Liu L, Daley GQ. Telomere Elongation in Dyskeratosis Congenita Induced Pluripotent Stem Cells. Blood. 114: 497-497. DOI: 10.1182/Blood.V114.22.497.497 |
0.4 |
|
| 2009 |
Ni Z, Knorr DA, Clouser CL, Southern P, Mansky LM, Park I, Kaufman DS. Natural Killer Cells Derived From Human Pluripotent Stem Cells Provide a Novel Method to Treat HIV-1 Infection. Blood. 114: 280-280. DOI: 10.1182/Blood.V114.22.280.280 |
0.34 |
|
| 2009 |
Grauer M, Konantz M, Niebuhr NI, Kanz L, Park I, Daley GQ, Lengerke C. Hematopoietic Development From Human Induced Pluripotent Stem Cells. Blood. 114: 2530-2530. DOI: 10.1182/Blood.V114.22.2530.2530 |
0.46 |
|
| 2009 |
Konantz M, Brugman MH, Park I, Daley GQ, Nuesslein-Volhard C, Baum C, Lengerke C. The Zebrafish Homologue of the Murine Ecotropic Viral Integration Site-1 (. Evi-1) gene Regulates Zebrafish Embryonic Blood Development. Blood. 114: 1461-1461. DOI: 10.1182/Blood.V114.22.1461.1461 |
0.431 |
|
| 2009 |
Ball MP, Billy Li J, Gao Y, Lee J, LeProust EM, Park I, Xie B, Daley GQ, Church GM. Erratum: Corrigendum: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells Nature Biotechnology. 27: 485-485. DOI: 10.1038/Nbt0509-485B |
0.312 |
|
| 2008 |
Müller FJ, Laurent LC, Kostka D, Ulitsky I, Williams R, Lu C, Park IH, Rao MS, Shamir R, Schwartz PH, Schmidt NO, Loring JF. Regulatory networks define phenotypic classes of human stem cell lines. Nature. 455: 401-5. PMID 18724358 DOI: 10.1038/Nature07213 |
0.433 |
|
| 2008 |
Park IH, Lerou PH, Zhao R, Huo H, Daley GQ. Generation of human-induced pluripotent stem cells. Nature Protocols. 3: 1180-6. PMID 18600223 DOI: 10.1038/Nprot.2008.92 |
0.44 |
|
| 2008 |
Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 451: 141-6. PMID 18157115 DOI: 10.1038/Nature06534 |
0.343 |
|
| 2008 |
Tolar J, Park I, Xia L, Osborn M, McElmurry RT, Orchard PJ, Daley GQ, Blazar BR. Patient-Specific Induced Pluripotent Stem Cells in Hurler Syndrome Blood. 112: 386-386. DOI: 10.1182/Blood.V112.11.386.386 |
0.45 |
|
| 2007 |
Park IH, Daley GQ. Debugging cellular reprogramming. Nature Cell Biology. 9: 871-3. PMID 17671453 DOI: 10.1038/Ncb0807-871 |
0.44 |
|
| 2006 |
West JA, Park IH, Daley GQ, Geijsen N. In vitro generation of germ cells from murine embryonic stem cells. Nature Protocols. 1: 2026-36. PMID 17487192 DOI: 10.1038/Nprot.2006.303 |
0.426 |
|
| 2006 |
Bachmann RA, Kim JH, Wu AL, Park IH, Chen J. A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1. The Journal of Biological Chemistry. 281: 7357-63. PMID 16407298 DOI: 10.1074/Jbc.M512218200 |
0.69 |
|
| 2005 |
Park IH, Chen J. Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation. The Journal of Biological Chemistry. 280: 32009-17. PMID 16043480 DOI: 10.1074/jbc.M506120200 |
0.371 |
|
| 2005 |
Park IH, Erbay E, Nuzzi P, Chen J. Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1. Experimental Cell Research. 309: 211-9. PMID 15963500 DOI: 10.1016/J.Yexcr.2005.05.017 |
0.71 |
|
| 2003 |
Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J. IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. The Journal of Cell Biology. 163: 931-6. PMID 14662739 DOI: 10.1083/Jcb.200307158 |
0.677 |
|
| 2003 |
Fang Y, Park IH, Wu AL, Du G, Huang P, Frohman MA, Walker SJ, Brown HA, Chen J. PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1. Current Biology : Cb. 13: 2037-44. PMID 14653992 DOI: 10.1016/J.Cub.2003.11.021 |
0.344 |
|
| 2002 |
Park IH, Bachmann R, Shirazi H, Chen J. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. The Journal of Biological Chemistry. 277: 31423-9. PMID 12087098 DOI: 10.1074/Jbc.M204080200 |
0.692 |
|
| Show low-probability matches. |